2021
DOI: 10.1134/s0006297921020103
|View full text |Cite
|
Sign up to set email alerts
|

CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…The CRABP1 gene produces the Cellular retinoic acid-binding protein 1. This protein is responsible for the delivery of Retinoic Acid (RA) to its receptors thereby regulating its bioavailability and metabolism [ 24 , 25 ]. RA is important for the development of a healthy placenta by regulating the function of trophoblast placental cells [ 26 ].…”
Section: Resultsmentioning
confidence: 99%
“…The CRABP1 gene produces the Cellular retinoic acid-binding protein 1. This protein is responsible for the delivery of Retinoic Acid (RA) to its receptors thereby regulating its bioavailability and metabolism [ 24 , 25 ]. RA is important for the development of a healthy placenta by regulating the function of trophoblast placental cells [ 26 ].…”
Section: Resultsmentioning
confidence: 99%
“…Patients with low serum retinol concentrations have less cellular retinoic acid availability and lower CRABP1 concentrations. In addition, there is an association between the concentration of CRABP2 and CRABP1; it has been observed that when there is a low synthesis of the CRABP2 protein, the expression of CRABP1 is suppressed (Enikeev et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Our data revealed that CRABP2 was directly targeted by miR‐486‐3p, and circ_0011298 sponged miR‐486‐3p to upregulate CRABP2 expression. Many researches have suggested that CRABP2 is involved in regulation of the drug sensitivity in several cancers 31‐33 . In addition, Favorskaya et al reported that CRABP2 mRNA level was elevated in NSCLC samples 34 .…”
Section: Discussionmentioning
confidence: 99%
“…Many researches have suggested that CRABP2 is involved in regulation of the drug sensitivity in several cancers. 31 , 32 , 33 In addition, Favorskaya et al reported that CRABP2 mRNA level was elevated in NSCLC samples. 34 Moreover, Kim et al proved that plasma CRABP2 level was increased in NSCLC patients.…”
Section: Discussionmentioning
confidence: 99%